13TSB_SynBio Enhanced discovery and scalable synthesis of therapeutic cyclic peptides

13TSB_SynBio 治疗性环肽的增强发现和规模化合成

• 批准号: BB/L004429/1
• 负责人: Marcel Jaspars
• 金额: $ 17.98万
• 依托单位: University of Aberdeen
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2013
• 资助国家: 英国
• 起止时间: 2013 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FL004429%2F1
• 关键词: 13TSB_SynBio; Enhanced; discovery; scalable; synthesis

Natural products often have very desirable biological and material properties. In the future there will be immense pressureto produce economically valuable materials with much reduced environmental impact. This means the IndustrialBiotechnology sector (which is related to, but distinct from the Pharmaceutical Industry) in the UK has a golden opportunityto harness world class science. This proposal links first class academic science with unique expertise available in aninnovative small company, Ingenza. The main aim of the project is to develop a bacterial system (cell factory) for theproduction of novel customizable and highly modified cyclic peptides in significant quantities. Cyclic peptides are found asantibiotics, anticancer agents, in hormone therapy and in immune system modifying agents. In addition to their directmedicinal role, they are also very useful tools in studying biological processes, this second role, as tools, isunderdeveloped simply because natural products are hard to make in sufficient amounts. The proposed work will solvethese problems by providing a plug 'n' play system in which changes can be made simply and quickly to the 'cell factory' toproduce a vast array of cyclic peptides at a useful scale.

天然产品通常具有非常理想的生物和材料特性。在未来，将有巨大的压力来生产经济上有价值的材料，同时大大减少对环境的影响。这意味着英国的工业生物技术部门（与制药业有关，但又与制药业不同）有一个利用世界级科学的黄金机会。该提案将一流的学术科学与创新小公司Ingenza的独特专业知识联系起来。该项目的主要目的是开发一种细菌系统（细胞工厂），用于大量生产新型可定制和高度修饰的环肽。环肽被发现作为抗生素，抗癌剂，在激素治疗和免疫系统修饰剂.除了它们的直接药用作用外，它们也是研究生物过程的非常有用的工具，这第二个作用，作为工具，仅仅是因为天然产品很难制造足够的数量。拟议的工作将通过提供一个即插即用系统来解决这些问题，在该系统中，可以简单快速地对“细胞工厂”进行改变，以生产大量有用规模的环肽。